Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
Crossref DOI link: https://doi.org/10.1186/s12885-016-2945-2
Published Online: 2016-11-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wong, Eric T.
Timmons, Joshua
Callahan, Amy
O’Loughlin, Lauren
Giarusso, Bridget
Alsop, David C.
Funding for this research was provided by:
A Reason to Ride
Integrated Therapeutics
License valid from 2016-11-22